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Abstract  
Introduction: Candidal infections are a serious problem in neonatal intensive care units, increasing morbidity and mortality in low birth 
weight infants in addition to escalating health-care costs. Studies exploring the epidemiology of candidiasis in developing country hospitals 
are rare. This retrospective case-control study aimed to evaluate epidemiology and risk factors associated with candidiasis in a neonatal 
intensive care unit in Karachi, Pakistan.   
Methodology: Cases (neonates (age < 28days, (n = 45) with NICU discharge diagnosis of candidal sepsis or candidemia between January 
1996 and December 2006 were matched with controls (newborns with discharge diagnoses other than the above during the same study 
period) for gender, gestational age, and admission within 72 hours of admission of an index case. Risk factors were identified and clinical 
course and outcomes (discharge disposition) described. P-value and match-adjusted odds ratios were calculated. 
Results: A frequency of 0.9% candidemia was documented in the NICU. The incidence was highest (46%) in VLBW (< 1500gm). C. 
albicans was the leading causative organism (55%), and neonatal risk factors identified were mechanical ventilation (> 7 days), positive 
bacterial culture, and duration of hospitalization of > 7 days.  
Conclusions: Prolonged ventilation, positive bacterial blood culture, and prolonged duration of NICU stay were the major risk factors 
associated with newborn fungal sepsis in our center. Presence of antenatal care was a significant protective factor in our subset of neonatal 
population.  
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Introduction 
Candidiasis in neonatal intensive care units has 
increased steadily in incidence over the last two 
decades [1,2]. Although a few reports suggest a 
gradual decline, most surveillance studies have 
reported a rising trend. The reported incidence ranges 
between 1.6% and 9% in very low birth weight 
(VLBW), and 10% and 16% in extremely low birth 
weight (ELBW) infants [3] with a clear association 
with decreasing gestational age [4,5]. 
Candida species accounts for 9% to 13% of all 
hospital acquired blood stream infections (BSIs) [6]. 
The mortality associated with C. albicans is reported 
to be 44% [7] in VLBW infants and 30% to 75% in 
ELBW infants [1,8-10]. This trend is concurrent with 
the increasing survival of premature newborns 
secondary to advancement in intensive care. Preterm, 
low birth weight babies are more vulnerable to acute 
fungal sepsis, primarily because of an immature 
immune system, invasive interventions, and 
prolonged use of antimicrobials that serve as risk 
factors for fungal colonization [11]. Preceding 
colonization is an important risk factor for 
subsequent dissemination and invasive disease [12-
15]. 
Fungal colonization of the skin, gastrointestinal 
tract, and respiratory mucosa occurs in 26.7% to 
62.5% of sick neonates, usually in the first two weeks 
of life [13,16]. Candida species can spread through 
vertical transmission from maternal flora or via 
horizontal transmission from hands of health-care 
workers. Known risk factors for fungal infection 
include the use of H2 blockers, steroids, 
aminophylline, prior colonization, presence of central 
lines, prolonged use of broad-spectrum antibiotics, 
total parenteral nutrition, and extended length of stay 
in the NICU [7,17,18]. The absence of specific 
clinical and laboratory criteria coupled with the delay 
in culturing the organism from body fluids has 
prompted the use of antifungal prophylaxis in certain 
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centers [19,20]. Although C. albicans remains the 
most common fungal pathogen isolated from blood 
and body tissue, recent literature shows an increased 
prevalence of non-candida species [21,22]. 
Practically all the published literature on 
candidaemia in intensive care units is from developed 
countries [4,11,23,24].  This study was conceived 
with the primary objective to document the 
epidemiology, clinical course, and specific clinical 
and biochemical markers that aid in the diagnosis of 
candidemia. Secondarily, the study aimed to identify 
maternal and perinatal risk factors for the 
development of candidemia in our setting and discuss 
our data compared with existing literature from the 
developed world. 
 
Methodology 
Study population and identification 
This matched case control study was performed 
by file reviews of neonates with discharge diagnosis 
of candidiasis/candidemia/fungal from the neonatal 
intensive care unit (NICU) at the Aga Khan 
University Hospital, Karachi, Pakistan, from January 
1996 to December 2006.  
Cases were identified through two routes: (i) the 
International Classification of Disease (ICD – 2007) 
for fungemia, fungal sepsis, and fungal infection 
(117.0-117.9) was used to retrieve appropriate files; 
and (ii) a meticulously maintained NICU logbook 
recording all discharge diagnoses was used to 
optimize file retrieval. We also reviewed the blood 
cultures of all cases and controls for final case 
confirmation. A case was defined as an NICU 
inpatient with candidal species isolated from blood. 
A control was matched to a case for gestational age, 
gender, and time of admission (within 72 hours of 
admission of an index case). A control was defined as 
a neonate admitted in NICU whose blood cultures 
were negative for candidal species.  
We identified 45 patients fulfilling case 
definition during the 10-year period. The number of 
matched controls was 36.   
Serious adverse events following antifungal 
medication were defined as raised creatinine level ( > 
1.4 in preterm and  > 1.0 in term infants), hematuria, 
decreased urine output ( > 1mL/kg/hr), hypokalemia 
(potassium < 3 mEq/L), and arrhythmias. 
 
Study setting  
The NICU at the Aga Khan University hospital, a 
tertiary care unit, is a level 111, thirteen-bedded unit 
(having 12 ventilators) with provision of all neonatal 
and subspecialty care with the exception of 
extracorporeal membrane oxygenation and inhaled 
nitric oxide. Of an average 4,000 in-facility deliveries 
per year, 11% (450) are referred to the NICU. 
Average referrals from outside sources are 
approximately 200 to 250 per year. Premature infants 
comprise 15% to 20% of the total number of 
deliveries in the hospital. The unit serves as a tertiary 
care centre for a diverse population and receives 
patients from secondary care hospitals from within 
and outside the city. An empiric antibiotic regime is 
initiated based on high perinatal risk factors for early 
onset sepsis. The current hospital antibiotic policy 
recommends initial empiric use of ampicillin-
gentamicin for neonates born within the facility and 
cefotaxime-amikacin for neonates referred from 
elsewhere.  
 
Organism identification 
The germ tube test (GTT) method was used to 
differentiate between C. albicans and non-albicans 
(NAC) species. Non-albicans species were further 
identified by cornmeal tween agar plates and reading 
the morphology at 72 hours. API 20C AUX 
(bioMérieux SA, Lyon France) was used where 
identification could not be established by the above 
methods. 
 
Statistical analysis  
All collected data was entered in duplicate in 
FoxPro based data management system (Microsoft 
Corp 1998, Redmond WA, USA). Key punching 
errors were rectified and logical errors corrected. 
Statistical analyses were performed by SPSS version 
16 (IBM, NY, USA). The demographic features 
recorded for cases and controls  included postnatal 
age (PNA) in days, weight (kg/gm), gender, year and 
date of admission, gestational age (weeks), maternal 
risk factors (prolonged rupture of membrane, fever, 
urinary tract infections, lack of antenatal care), 
APGAR score, antenatal care, history of antibiotics, 
presence of thrombocytopenia (<150,000/mm3), and 
duration of mechanical ventilation. Data was also 
collected on bacterial cultures (blood, urine, and 
trachea), length of stay, catheterization (central line 
and urinary), use of total parenteral nutrition (TPN), 
types and duration of antibiotics used before positive 
fungal culture, and discharge disposition. Additional 
information related to acquired fungal infection 
including candidal versus  
non-candidal, site of isolation (blood, urine, trachea, 
CSF), duration of antifungal treatment, and 
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radiological work-up (ultrasound head, abdomen, and 
echocardiography), were recorded. Continuous 
variables (age in days, weight in grams, antibacterial 
therapy, antifungal therapy, TPN duration, and length 
of stay) were dealt with in means and standard 
deviation. Categorical variables (gender, poor 
perfusion (3-5 seconds), abdominal distension, low 
platelets, and duration of bacterial culture positivity 
after hospitalization were analyzed as frequencies 
and percentages. We compared cases and controls 
among NICU inpatients to identify risk factors 
associated with acquired candidal infection and the 
level of significance was set at 0.05. Chi-square tests 
and Fisher exact tests were applied where necessary. 
Univariate analysis was performed for all variables 
and a cutoff of 0.2 was considered significant. 
Multivariate analysis was performed for those 
variables that were significant at univariate analysis. 
The final model was adjusted for confounding. 
Interactions between biologically plausible 
independent variables were checked.   
 
Ethical approval  
An exemption as granted by the study was 
approved by the Ethical Review Board (ERB) of the 
Aga Khan University Hospital, Karachi (1514-Ped-
ERC-2010).  
 
Results  
Epidemiology and demographic features of study 
population (Table 1) 
Forty-five patients were diagnosed as cases 
during the study period between 1996 and 2006. This 
constituted 0.9% of 4,829 neonates admitted during 
the ten-year period. The frequency of cases per year 
varied. The highest rate occurred in 2005 (5.9%, n = 
22), followed by 2.7% (n = 12) in 2004, and 1.4% (n 
= 8) in 2006. The incidence of candidemia was 
highest (46%) among VLBW ( < 1500gm) with a 
male preponderance (71%). Umbilical artery and/or 
vein catheterization was done in 42% (n = 19) of the 
cases and 50% (n = 18) of the controls; however, 8% 
(n = 4) of the cases also had an additional Hickman 
line. Two (4%) of the cases had indwelling catheters 
for urine output monitoring. CSF fungal cultures, 
though not part of the case definition, were sent in 
8% (n = 4) of cases and 16% (n = 6) of controls. All 
were negative. Yield of bacterial (blood, urine, and 
tracheal) cultures and comparative base line 
characteristics among cases and controls are shown in 
Table 1. 
Mycology 
Eighty-nine isolates from forty-five neonates 
were positive for Candida spp. C. albicans was the 
leading causative organism isolated in 55% of all 
cases diagnosed (n = 49 isolates, combining all sites), 
followed by C. tropicalis (21%), and C. glabrata 
(9%). Four cases had duplicate isolates. All cases 
with C. parapsilosis had central lines in place and 
received total parenteral nutrition (TPN). Table 2 
shows the Candida sub-species data along with sites 
of isolation. 
 
Antifungal treatment and adverse events 
Sixty-eight percent of the neonates with 
candidaemia received antifungal treatment (n = 31). 
Of these, 19 were treated with Amphotericin B, nine 
with Fluconazole, and three received a combination 
of Amphotericin and Fluconazole. The average 
duration of Amphotericin B therapy was 15 days and 
the mean dose per kg/day was 1.23mg. The average 
duration of oral Fluconazole was seven days. The 
mean dose used was 3.85mg/kg/day. Ten cases (22%) 
did not receive any treatment. In seven of these 10 
untreated patients, the reason for deferring treatment 
could not be ascertained from the records; the other 
three had cultures reported after discharge with no 
subsequent follow-up visits.  
No serious significant adverse events were 
documented. There was no unacceptably (two-fold 
rise) in serum hepatic enzymes or clinical signs of 
hepatotoxicity and nephrotoxicity, with the exception 
of one neonate with significantly raised creatinine 
and renal failure. The electrolytes remained normal 
during Amphotericin B treatment with creatinine 
levels of 1.3 mg/dL (preterm 1.3 ± 0.07 and 0.3-1.0 
in term infants) before fungal therapy and 0.5 mg/dL 
after treatment. Similarly, serum potassium remained 
normal throughout treatment at 4.0 meq/L (5.6 ± 0.5 
in preterm and 5.92 ± 0.8 in term). 
 
Risk factors identification (Table 3) 
We performed conditional logistic regression 
analysis. Table 3 shows the crude and adjusted odds 
ratios of the important risk factors along with their 
Confidence Interval (CI). We identified lack of 
antenatal care, mechanical ventilation ( > 7 days), 
concomitant positive bacterial blood culture, and 
hospitalization (> 7 days) as risk factors for 
development of candidemia in our cases. Transfusion 
of blood products was a significant risk factor at the 
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Variable 
Cases 
n = 45, (%) 
Control 
n = 36, (%) 
Preterm* 32 (71) 26 (72) 
SGA* 23 (52) 20 (55) 
Weight on admission   
Male* 32 (71) 26 (72) 
Age in days (on admission) 12.29 ± 16 3.97 ± 10.45 
Weight in grams (on admission) 1792.6 ± 886.53 2041.82 ± 944.45 
Born outside our hospital 29 (64) 14 (39) 
Received antenatal care 30 (66) 31 (88) 
Mode of delivery (SVD) 25 (55) 21 (60) 
Maternal factors 
 PROM 9 (20) 2 (5) 
 Fever 6 (13) 1 (3) 
 UTI 5 (11) 2 (5) 
 GDM 4 (8) 3 (8) 
 HTN 7 (15) 4 (11) 
Neonatal factors 
 Required mechanical ventilation 32 (71) 25 (69) 
 Days on mechanical ventilation 19 ± 15 5.2 ± 4 
 Intubation >2 times 16 (35) 5 (14) 
 Catheterizations of vessels ** 23 (51) 18 (50) 
Signs of sepsis   
 Lethargy 
 Abdominal distention/gastric aspirates 
 Thrombocytopenia 
28 (62) 
20 (44) 
27 (60) 
8 (22) 
4(11) 
6 (17) 
TPN duration in days 20.9 ± 13.5 13.2 ± 14.6 
Bacterial culture positivity   
 Blood 
 Tracheal 
 Urine 
29 (64) 
14 (31) 
8 (18) 
10 (27) 
3 (8) 
2 (5) 
Anti-bacterial therapy received (in days)   
 Ampicillin 
 Gentamycin 
 Claforan 
 Amikacin 
 Meropenem 
 cloxacillin 
8.6  ± 5 
6.4 ± 4 
10.3 ± 7 
12.2 ± 8 
11.8 ± 7 
6.4 ± 5 
13.2 ± 14 
5.3 ± 3 
5 ± 2 
8.1 ± 6 
9.3 ± 6.5 
5.8 ± 4 
Duration of hospitalization (in days) 30.8 ± 19.33 19.2 ± 20.10 
Neonatal outcome (died) 11 (24) 6 (13) 
Table 1. Demographic and neonatal characteristics in cases and controls 
 
*Cases & Controls were match on prematurity, SGA and gender 
**Umbilical vessels and/or other central venous access 
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univariate level but was found to be insignificant on 
adjusted analysis. Table 4 shows the conditional 
logistic regression analysis. 
 
Outcomes 
Mortality among our candidal sepsis cohort was 
24% (n = 11); 40% of expiries had C. albicans 
isolates in blood, while 30% had C. tropicalis. C. 
parapsilosis was isolated in four neonates. Of the 
four neonates with C. Parapsilosis infection, three 
had central lines in place and received total parenteral 
nutrition. 
 
Discussion 
Reporting of fungal blood-stream infection and 
the spectrum of species involved are essential 
measures in any intensive care unit in order to 
implement appropriate preventive and therapeutic 
strategies [26]. We report a frequency of 0.93% of 
neonatal candidaemia, which is comparable to the 
incidence reported from developed countries 1.6% to 
5% [9,11,17]. 
Major clinical markers of neonatal candidemia 
reported in the literature include temperature 
instability and thrombocytopenia. We did not record 
any significant episodes of hypothermia or 
hyperthermia; however, thrombocytopenia (platelet 
count < 150,000/mm3)) was a consistent finding in 
our neonatal fungal cohort with an adjusted odds 
ratio of 2.07 (0.22-19.17), which is comparable to 
results reported in the published literature [22].  
C. albicans was the leading causative organism 
(55%) in our study followed by C. tropicalis (21%) 
and C. glabrata (9%). C. parapsilosis was isolated in 
only two neonates. Our findings were different from 
that reported by Imad et al. [22] and others who  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
found increasing rates of non-albicans candida, 
namely C. parasipolosis [27]. C. parapsilosis is 
known to be associated with the use of total 
parenteral nutrition and central catheters. 
Observational studies have recorded an association of 
prolonged duration of candidemia and increased 
mortality associated with the delayed removal of 
central lines [28]. In our subset, the duration of 
parenteral nutrition was short, with an average of two 
weeks, and catheters removed on the day that the 
blood cultures were positive for candida species.  
The major risk factors identified in our case 
control study were mechanical ventilation ( > 7 days), 
presence of bacterial blood-stream infection before 
the diagnosis of fungal infection, and duration of 
hospitalization. These findings are similar to those 
reported in earlier studies [11]. There was a 
significant difference in the rate of bacterial isolates 
among cases and controls (64% vs. 27%, p = 0.002), 
further validating the findings reported from 
developed countries [1,29].  
Provision of antenatal care was a protective 
factor for neonatal candidemia in our identified 
cohort; however, we were unable to find studies from 
the developed countries that have evaluated this 
factor. We hypothesize that the presence of regular 
antenatal visits may have led to earlier detection and 
treatment of maternal fungal colonization, resulting 
in the reduction in neonatal colonization and 
dissemination. 
Antifungal treatment was effective and safe in 
our neonates. Sixty percent of our cases received 
antifungal therapy without any significant adverse 
effects; however, previous studies by Wang et al. and 
Imad et al. [10] from developed countries have  
 
 Blood Urine Trachea Total Mortality  
Candida Albicans 27 19 3 49 (55) 6/24 0.25 
Candida Tropicalis 10 8 1 19 (21) 2/12  0.16 
Candida Glabrata 3 5 -- 8 (9) 1/6    0.16 
Candida Parapsilosis 2 3 -- 5  
Candida Pediculosa 4 -- -- 4  
Candida Guiliermondil 1 -- -- 1  
Candida Rugosa 1 -- -- 1  
Candida Humicola 1 -- -- 1  
Candida Krusei 1 -- -- 1  
Table 2. Isolates of Candida sub-species with sites of isolation 
 
Total number of isolates  89 
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Antifungal therapy Alive  Died p-value OR (95% - CI) 
Amphotericin 19 8 0.482 2.105 (0.475 – 9.338) 
Fluconazole 9 6 0.086 3.333 (0.814 – 13.658) 
Amphotericin + Fluconazole 3 4 0.155 4.889 (0.851 – 28.079) 
Variables Cases Controls p-value Crude OR 
(CI) 
Adjusted OR 
(CI) 
Not received antenatal care 15 3 0.044 3.10 (1.002 
– 9.594) 
3.461 (0.378 – 
31.691) 
Born at our institute 22 16 0.024 0.351 
(0.142 – 
0.869) 
0.865 (0.152 – 
4.931) 
TPN duration (>7 days) 15 4 0.051 5.625 
(1.052 – 
30.133) 
 
Ventilation (>7 days) 25 8 0.001 7.143 
(2.167 – 
23.544) 
5.126 (0.562 – 
46.785) 
Intubation (>2 times) 16 5 0.006 5.0 (1.530 
– 16.339) 
 
Bacterial culture 
 Blood 
 Trachea 
 Urine 
 
29 
14 
8 
 
10 
3 
2 
 
0.001 
0.142 
0.172 
 
4.713 
(1.821 -1 
12.198) 
4.968 
(1.301 – 
18.969) 
3.676 
(0.729 – 
18.535) 
 
1.933 (0.348 – 
10.729) 
Signs of deterioration 
 Lethargy 
 Abdominal distension / Gastric 
aspirates 
 Thrombocytopenia 
 
28 
20 
 
27 
 
8 
4 
 
6 
 
<0.001 
0.001 
 
<0.001 
 
7.50 (2.598 
– 21.652) 
6.48 (1.939 
– 21.126) 
 
5.765 
(2.142 -
15.518) 
 
17.476 (2.334 – 
130.857) 
Duration of hospitalization 35 15 0.001 4.9 (1.865 
– 23.873) 
 
Neonatal outcome 
 Died 
 
11 
 
6 
 
0.393 
 
1.618 
(0.533 – 
4.905) 
 
Table 3. Antifungal treatment and mortality rates in neonates with candidemia 
 
*31 patients (69%) received antifungal therapy. 
 
Table 4. Risk Factors for candidemia; crude and adjusted OR 
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shown an increased rate of complications beyond 
seven days of treatment. 
There are certain limitations in our study inherent 
in a retrospective chart review. We could not manage 
a 1:1 case-control ratio due to stringent matching 
criteria. Reasons for anti-fungal treatment deferral in 
7 of 10 patients could not be evaluated due to poor 
documentation. Three out of ten had culture results 
reported post-discharge and there was a failure to 
contact them; hence, the clinical outcome of the ten 
patients remains unknown. Though powered to detect 
significant risk factors for fungal sepsis, this is a 
single centre study and could benefit by pooling data 
from other similarly placed centers in other 
developing countries. 
In spite of these limitations, this study contributes 
valuable information to the body of literature. To our 
knowledge, this is the first study from South Asia on 
the epidemiology of neonatal candidemia. It is a 
matched case-control study detecting possible risk 
factors predisposing candidemia in NICU inpatients. 
Strict criteria for controls were applied to remove 
possible confounders, such as environmental factors, 
NICU outbreaks and institutional standards. A 
retrospective cohort allowed a time-effective analysis 
of a relatively rare condition over 10 years. Stringent 
measures were utilized to enroll every positive fungal 
sepsis patient, fulfilling case definition. Conditional 
logistic regression analysis was used to calculate the 
crude and adjusted-odds ratio for risk factor 
identification.  
This is the first local review of candidemia sepsis 
in NICU settings that identifies epidemiology, 
frequency, clinical profile and risk factors, and safety 
profiles of antifungal and clinical outcomes in 
inpatient newborns. These findings can serve as a 
template for the development of local guidelines for 
prevention and appropriate treatment of candidal 
sepsis in our intensive care unit. 
 
Conclusion 
Candidemia in the NICU is associated with a 
very high mortality, especially with escalating 
antibiotic use. Major risk factors are prolonged 
ventilation (>7 days), positive bacterial blood culture, 
and prolonged duration of NICU stay (>7 days). 
Antenatal care has a protective impact on neonatal 
fungal infection in our settings.  
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